Bioventus Inc.

Industry

  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Biotechnology
    • Large Molecule
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • Bioventus Inc.
  • Bioventus Coöperatief U.A.
  • BioStructures LLC
  • Bioness, Inc.
  • CartiHeal Ltd.
  • Bioness, Cartiheal, Misonix
See more in Biomedtracker

Latest on Bioventus Inc.

In Vivo

Dealmaking Quarterly Statistics, Q4 2024

 
• By Maureen Riordan and Deanna Kamienski

Biopharma merger and acquisition value for the fourth quarter of 2024 reached $9.4bn from 34 transactions, 15 of which had disclosed values. At the top was H. Lundbeck’s $2.6bn purchase of publicly tr

Medtech Insight

Smith & Nephew To Acquire Cartiheal For Up To $330M

 
• By Marion Webb

Under the agreement, Smith & Nephew plc will buy Israel-based Cartiheal for an initial $180m in cash and up to $150m more contingent on financial performance, the companies announced on 22 November.

Medtech Insight

News We’re Watching: Cancer Screening Partnership, New Abbott Electrophysiology Head, V-Champs AI Challenge

 
• By Hannah Daniel, Reed Miller, Elizabeth Orr, and Marion Webb

Bioventus Divests Wound Business To LifeNet Health To Enhance Liquidity Bioventus Inc. announced it signed a definite agreement to sell its wound care business to LifeNet Health for about $85m. Th

Medtech Insight

Minute Insight: Bioventus Completes Cartiheal Acquisition Following Agili-C Approval

 
• By Reed Miller

Bioventus is exercising its option to buy Cartiheal and plans to launch Cartiheal’s Agili-C knee implant in the third quarter. Agili-C is a porous, biodegradable scaffold for treating cartilage and